This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
B cell (Raji)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Immature bone marrow-derived dendritic cell
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (MHCC-97L)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Mature bone marrow-derived dendritic cell
Pancreatic ductal epithelial cells (MPDC)
Plasma
Serum
By sample status
24 hr culture
72 hr culture
Mild hand, foot, and mouth disease
Normal
Sample A_Biooscientific
Sample A_Illumina
Sample A_NEB
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Transplant islets into mouse xenotransplantation-rejected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-9-3p
MIMAT0000442
1.8e-3
4.4e-1
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2011;2:282. doi: 10.1038/ncomms1285.
MIPF0000014_2
25
/
0
/
25
mmu-miR-9-3p
MIMAT0000143
0.0e+0
1.9e-1
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Blood. 2012 Jan 19;119(3):756-66. doi: 10.1182/blood-2011-02-338004. Epub 2011 Oct 26.
MIPF0000014_2
25
/
0
/
25
mmu-miR-9-3p
MIMAT0000143
0.0e+0
3.4e-1
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Blood. 2012 Jan 19;119(3):756-66. doi: 10.1182/blood-2011-02-338004. Epub 2011 Oct 26.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
2.2e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
3.2e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
2.4e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
2.4e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
2.2e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
2.3e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
8.3e-2
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
9.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
bfl-miR-9-3p
MIMAT0009477
0.0e+0
2.5e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9-3p
MIMAT0003650
0.0e+0
1.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
9.6e-7
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
3.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
bfl-miR-9-3p
MIMAT0009477
0.0e+0
3.0e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
bta-miR-9-3p
MIMAT0012549
0.0e+0
3.3e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
sko-miR-79
MIMAT0009618
0.0e+0
6.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
6.9e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
spu-miR-9-3p
MIMAT0009661
0.0e+0
1.1e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
1.3e-4
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
9.0e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
sme-miR-9a-3p
MIMAT0012146
0.0e+0
3.7e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
2.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
oan-miR-9-3p
MIMAT0006793
0.0e+0
3.2e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9-3p
MIMAT0003650
0.0e+0
5.8e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
bfl-miR-9-3p
MIMAT0009477
0.0e+0
1.7e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
oan-miR-9-3p
MIMAT0006793
0.0e+0
6.4e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
sme-miR-9a-3p
MIMAT0012146
0.0e+0
1.8e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9-3p
MIMAT0003650
0.0e+0
4.0e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
xtr-miR-9b-3p
MIMAT0003556
0.0e+0
1.0e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000014_2
25
/
0
/
25
dme-miR-79-3p
MIMAT0000352
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000014_2
25
/
0
/
25
cel-miR-79-3p
MIMAT0000051
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
4.8e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
4.7e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000014_2
25
/
0
/
25
mmu-miR-9-3p
MIMAT0000143
0.0e+0
2.8e-2
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
0.0e+0
2.7e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
3.0e-3
3.0e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000014_2
25
/
0
/
25
hsa-miR-9-3p
MIMAT0000442
3.9e-2
3.9e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000014_2
25
/
0
/
25
[1]